PEDV-S HR2L, PCov-S HR2L

General Information


DRACP ID  DRACP03997

Peptide Name   PEDV-S HR2L, PCov-S HR2L

Sequence  FNATYLKLTGEIADLEQRSESLRNTTEELQSLIYNINNTLVDLEWLNRVE

Sequence Length  50

UniProt ID  Q91AV1 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antiviral



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C258H411N69O87

Absent amino acids  CHMP

Common amino acids  L

Mass  674570

Pl  4.01

Basic residues  4

Acidic residues  9

Hydrophobic residues  18

Net charge  -5

Boman Index  -11268

Hydrophobicity  -48.4

Aliphatic Index  109.2

Half Life 
  Mammalian: >20 hour
  Yeast: >20 hour
  E.coli: ?

Extinction Coefficient cystines  8480

Absorbance 280nm  173.06

Polar residues  17

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 29203391

Title  Identification of a peptide derived from the heptad repeat 2 region of the porcine epidemic diarrhea virus (PEDV) spike glycoprotein that is capable of suppressing PEDV entry and inducing neutralizing antibodies

Doi Not available

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  15259

DRACP is developed by Dr.Zheng's team.